Contents

Spondyloarthropathy

Spondyloarthropathy
Specialty	Rheumatology

Spondyloarthropathyorspondyloarthrosis refers to any joint disease of the vertebral column. As such, it is a class or category of diseases rather than a single, specific entity. It differs from spondylopathy, which is a disease of the vertebra itself, but many conditions involve both spondylopathy and spondyloarthropathy.

Spondyloarthropathy with inflammation is called axial spondyloarthritis.^[1] In the broadest sense, the term spondyloarthropathy includes joint involvement of vertebral column from any type of joint disease, including rheumatoid arthritis and osteoarthritis, but the term is often used for a specific group of disorders with certain common features, which are often specifically termed seronegative spondylarthropathies. They have an increased incidence of HLA-B27, as well as negative rheumatoid factor and ANA. Enthesopathy is also sometimes present in association with seronegative spondarthritides^[clarify].

Non-vertebral signs and symptoms of degenerative or other not directly infected inflammation, in the manner of spondyloarthropathies, include asymmetric peripheral arthritis (which is distinct from rheumatoid arthritis), arthritis of the toe interphalangeal joints, sausage digits, Achilles tendinitis, plantar fasciitis, costochondritis, iritis, and mucocutaneous lesions. But lower back pain is the most common clinical presentation of the causes of spondyloarthropoathies; this back pain is unique because it decreases with activity.^{[citation needed]}

Seronegative spondyloarthropathy[edit]

Seronegative spondyloarthropathy (orseronegative spondyloarthritis) is a group of diseases involving the axial skeleton^[2] and having a negative serostatus.

"Seronegative" refers to the fact that these diseases are negative for rheumatoid factor,^[3] indicating a different pathophysiological mechanism of disease than is commonly seen in rheumatoid arthritis.

Conditions[edit]

The following conditions are typically included in the group of seronegative spondylarthropathies:

Some sources also include Behçet's disease^{[citation needed]} and Whipple's disease.^[7]

Common characteristics[edit]

These diseases have the following conditions in common:

• Seronegative (i.e. rheumatoid factor is not present)^[5]
• They are in relation to HLA-B27^[8]
• Inflammatory axial arthritis, generally sacroiliitis and spondylitis^[5]
• Oligoarthritis, generally with asymmetrical presentation^[5]
• Enthesitis^[5] (inflammation of the entheses, the sites where tendons or ligaments insert into the bone.^[9][10]), e.g. Plantar fasciitis, Achilles tendinitis, costochondritis.
• Familial aggregation occurs^[5]
• Extra-articular features, such as involvement of eyes (anterior uveitis), skin, genitourinary tract,^[5] and aortic regurgitation
• Overlap is likely between several of the causative conditions

Classification[edit]

Assessment of Spondylarthritis International Society (ASAS) criteria is used for classification of axial spondyloarthritis (to be applied for patients with back pain greater than or equal to 3 months and age of onset less than 45 years).^[11] It is of two broad types:^[12][13]

1. Sacroiliitis on imaging plus one SpA feature, or
2. HLA-B27 plus two other SpA features

Sacroiliitis on imaging:^[11]

• Active (acute) inflammation on MRI highly suggestive of SpA-associated sacroiliitis and/or
• Definite radiographic sacroiliitis

SpA features:^[11]

• Inflammatory back pain
• Arthritis
• Enthesitis
• Anterior uveitis
• Dactylitis
• Psoriasis
• Crohn's disease or ulcerative colitis
• Good response to NSAIDs
• Family history of SpA
• HLA-B27
• Elevated CRP

Treatment[edit]

Many patients have more than one of the spondyloarthritis disease manifestations. Some immunosuppressive drugs have shown efficacy in more than one of the diseases, e.g. tumor necrosis factor (TNF) inhibitors. But some of the immunosuppressive drugs are particularly effective for a specific inflamed tissue and approved in only one or two of the disease entities,^[14] so an interdisciplinary approach is required.

Epidemiology[edit]

Worldwide prevalence of spondyloarthropathy is approximately 1.9%.^[15]

References[edit]

External links[edit]